While facing these lawsuits, Eli Lilly and Novo Nordisk have initiated legal actions against compounding pharmacies, seen by some as efforts to deflect accountability for the adverse effects, blaming the compounding manufacturers for creating sub-par medications that have caused the side effects
Unpublished studies have also demonstrated that the IGF-1Rs of PPP treated cells are undergoing rapid downregulation
12.18.24 Study shows link between semaglutide use and NAION A December study showed that a once-weekly semaglutide doubles the five-year risk of developing non-arteritic anterior ischemic optic neuropathy (NAION)
FDA Fast Track designation for tirzepatide for the treatment of adults with obesity, or overweight with weight-related comorbidities
This executive order is a clear political overreach, driven by an ideological agenda to rewrite American history
It acts on appetite/satiety centres, helping to reduce food intake and supporting adherence to body recomposition strategies